Device Trial Radar · NCT01520337
Polyp Detection Rate After Single Oral Dose of Methylene Blue MMX Modified Release Tablets Administered to Subjects Undergoing Outpatients Colonoscopy
Last checked: Nov 19, 2026Latest source record: Feb 11, 2014 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
170
Actual
Start
Jan 2012
Primary completion
Mar 2013
Study completion Oct 2013
Sponsor
- Lead sponsor
- Cosmo Technologies LtdNot on our public-company list
- Sponsor type
- Industry
- First posted
- Jan 27, 2012
Design
- Study type
- Observational
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Polyp detection rate in colonoscopy following oral administration of MMX methylene blue tablets
Conditions
- Polyp and Adenoma Detection During Colonoscopy
Interventions
oral tablet dye for detection of polyps during colonoscopyDevice
oral tablet dye for improved detection of
Primary outcomes
What the sponsor says the trial is designed to measure.
- Polyp and adenoma detection rateTime frame: 1 day
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.